What is McKesson's prescription technology solutions — other?

McKesson (MCK) reported prescription technology solutions — other of $0 in Q1 2026.

How has McKesson's prescription technology solutions — other changed year-over-year?

McKesson's prescription technology solutions — other increased by 100.0% year-over-year, from -$1M to $0.

What does prescription technology solutions — other mean?

Includes miscellaneous costs or income items within the Prescription Technology Solutions segment that do not fit into standard categories like restructuring or impairments. This acts as a catch-all for segment-specific operational variances.

McKesson MCK Prescription Technology Solutions — Other

Other segment segments

North American Pharmaceutical

-$1M—

Medical-Surgical Solutions

$500K—

Oncology & Multispecialty

$0—

Similar metrics at other companies

PHRTechnology Solutions Segment — Other segment items

$13.96M+86.0%

SCSCSpecialty Technology Solutions — Other operating expenses

$66.29M+11.0%

FTKChemistry Technologies — Other segment items

$449K+16.3%

GDTechnologies — Other

-$3M-121%

ABMTechnical Solutions — Other segment expense

$91.7M+26.8%

AVN

AVNSTotal Specialty Nutrition Systems — Other segment items

-$100K0.0%

Other financials

Income statement

See full

Revenue$96.3B+6.0%

Gross profit$4.0B+11.1%

Operating income$2.2B+35.1%

Net income$1.7B+33.5%

EPS (diluted)$13.65+37.6%

Balance sheet

See full

Cash & equivalents$4.0B-33.3%

Total debt$2.3B-74.2%

Total equity-$2.2B-4.7%

Total assets$82.3B+9.6%

Cash flow

See full

Operating cash flow$3.4B-55.8%

CapEx$111.0M-34.3%

Free cash flow$3.3B-56.3%

Valuation

See full

Market cap$101.33B+17.0%

Enterprise value$99.63B+4.7%

P/E21.3×-6.1×

P/S0.3×0.0×

Profitability

See full

Gross margin3.6%-0.1pp

Operating margin1.5%+0.3pp

Net margin1.2%+0.3pp

FCF margin1.4%-0.1pp

Returns & leverage

See full

Return on equity36%—

Debt / equity2×—

Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserveTranslationAndOtherAdjustment.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's prescription technology solutions — other.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is McKesson's prescription technology solutions — other?: McKesson (MCK) reported prescription technology solutions — other of $0 in Q1 2026.
How has McKesson's prescription technology solutions — other changed year-over-year?: McKesson's prescription technology solutions — other increased by 100.0% year-over-year, from -$1M to $0.
What does prescription technology solutions — other mean?: Includes miscellaneous costs or income items within the Prescription Technology Solutions segment that do not fit into standard categories like restructuring or impairments. This acts as a catch-all for segment-specific operational variances.